VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Vaccine Mechanisms
VaximmutorDB
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Nov 01, 2021 To Nov 29, 2021:


Bacillus anthracis (Anthrax)

  1. Maison RM, Pierce CF, Ragan IK, Brown VR, Bodenchuk MJ, Bowen RA, Bosco-Lauth AM. Potential Use for Serosurveillance of Feral Swine to Map Risk for Anthrax Exposure, Texas, USA Emerging infectious diseases 27(12):3103-3110 2021 [PMID: 34808089]
  2. Zorigt T, Ito S, Isoda N, Furuta Y, Shawa M, Norov N, Lkham B, Enkhtuya J, Higashi H. Risk factors and spatio-temporal patterns of livestock anthrax in Khuvsgul Province, Mongolia PloS one 16(11):e0260299 2021 [PMID: 34797889]
  3. Mugo BC, Lekopien C, Owiny M. 'We dry contaminated meat to make it safe': An assessment of knowledge, attitude and practices on anthrax during an outbreak, Kisumu, Kenya, 2019 PloS one 16(11):e0259017 2021 [PMID: 34735481]
  4. Andryukov BG, Karpenko AA, Lyapun IN. Learning from Nature: Bacterial Spores as a Target for Current Technologies in Medicine (Review) Sovremennye tekhnologii v meditsine 12(3):105-122 2021 [PMID: 34795986]

Brucella (Brucellosis)

  1. Ong E, He Y. Vaccine Design by Reverse Vaccinology and Machine Learning Methods in molecular biology (Clifton, N.J.) 2414:1-16 2022 [PMID: 34784028]
  2. Chacón-Díaz C, Zabalza-Baranguá A, San Román B, Blasco JM, Iriarte M, Salas-Alfaro D, Hernández-Mora G, Barquero-Calvo E, Guzmán-Verri C, Chaves-Olarte E, Grilló MJ, Moreno E. Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle PloS one 16(11):e0260288 2021 [PMID: 34807952]
  3. Ramírez OLH, Santos HA, Paulino PG, van der Meer CS, Bautista JLR, Delgado ILJ, Obando JG, Garcia RR, da Costa Angelo I. Cross-sectional study of Brucella spp. using real-time PCR from bovine whole blood in Colombia Veterinary research communications 2021 [PMID: 34791575]
  4. Kornspan D, Brendebach H, Hofreuter D, Mathur S, Blum SE, Fleker M, Bardenstein S, Al Dahouk S. Protein Biomarker Identification for the Discrimination of <i>Brucella melitensis</i> Field Isolates From the <i>Brucella melitensis</i> Rev.1 Vaccine Strain by MALDI-TOF MS Frontiers in microbiology 12:712601 2021 [PMID: 34745025]
  5. Ali Ahmadi M, Saadati D, Najimi M, Ganjali H, Shah Karami F. Comparison of PCR and Conventional Serological Methods for Detection of <i>Brucella spp.</i> in Ovine and Caprine Blood Serum Archives of Razi Institute 76(3):445-452 2021 [PMID: 34824738]
  6. Azizi MR, Asli E, Behroozikhah AM, Khalesi B. Flow Cytometric Evaluation of CD4<sup>+</sup> and CD8<sup>+</sup> T-cell Immune Response in SPF Chickens Induced by Fowlpox Vaccine Archives of Razi Institute 76(3):429-436 2021 [PMID: 34824736]
  7. Goreyshi Amri SE, Shayegh J, Alamian S. Ovine visceral organs as reservoir candidate for <i>Brucella abortus</i> in Iran Iranian journal of veterinary research 22(3):230-233 2021 [PMID: 34777524]

Burkholderia pseudomallei (Melioidosis)

  1. Chapartegui-González I, Bowser S, Torres AG, Khakhum N. Recent Progress in <i>Shigella</i> and <i>Burkholderia pseudomallei</i> Vaccines Pathogens (Basel, Switzerland) 10(11) 2021 [PMID: 34832508]
  2. Grund ME, Kramarska E, Choi SJ, McNitt DH, Klimko CP, Rill NO, Dankmeyer JL, Shoe JL, Hunter M, Fetterer DP, Hedrick ZM, Velez I, Biryukov SS, Cote CK, Berisio R, Lukomski S. Predictive and Experimental Immunogenicity of <i>Burkholderia</i> Collagen-like Protein 8-Derived Antigens Vaccines 9(11) 2021 [PMID: 34835150]

Clostridium botulinum toxin (Botulism)

  1. Andryukov BG, Karpenko AA, Lyapun IN. Learning from Nature: Bacterial Spores as a Target for Current Technologies in Medicine (Review) Sovremennye tekhnologii v meditsine 12(3):105-122 2021 [PMID: 34795986]

Clostridium perfringens

  1. Poorhassan F, Nemati F, Saffarian P, Mirhosseini SA, Motamedi MJ. Design of a chitosan-based nano vaccine against epsilon toxin of <i>Clostridium perfringens</i> type D and evaluation of its immunogenicity in BALB/c mice Research in pharmaceutical sciences 16(6):575-585 2021 [PMID: 34760006]
  2. Hayati M, Tahamtan Y. Toxin typing of <i>Clostridium perfringens</i> Associated with Enterotoxaemia in Sheep in Fars Province Archives of Razi Institute 76(3):691-697 2021 [PMID: 34824761]
  3. Andryukov BG, Karpenko AA, Lyapun IN. Learning from Nature: Bacterial Spores as a Target for Current Technologies in Medicine (Review) Sovremennye tekhnologii v meditsine 12(3):105-122 2021 [PMID: 34795986]

Coxiella burnetii (Q fever)

  1. Fan Z, Jan S, Hickey JC, Davies DH, Felgner J, Felgner PL, Guan Z. Multifunctional Dendronized Polypeptides for Controlled Adjuvanticity Biomacromolecules 2021 [PMID: 34788023]
  2. Kumaresan V, Alam S, Zhang Y, Zhang G. The Feasibility of Using <i>Coxiella burnetii</i> Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever Frontiers in immunology 12:754690 2021 [PMID: 34795669]

Cryptosporidium parvum

  1. Li T, Liu H, Jiang N, Wang Y, Wang Y, Zhang J, Shen Y, Cao J. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response PLoS neglected tropical diseases 15(11):e0009949 2021 [PMID: 34818332]
  2. Ryan U, Zahedi A, Feng Y, Xiao L. An Update on Zoonotic <i>Cryptosporidium</i> Species and Genotypes in Humans Animals : an open access journal from MDPI 11(11) 2021 [PMID: 34828043]

Eastern equine encephalitis virus

  1. Powers AM. Resurgence of Interest in Eastern Equine Encephalitis Virus Vaccine Development Journal of medical entomology 2021 [PMID: 34734632]

Ebola virus

  1. Puthanakit T, Anugulruengkitt S, Jantarabenjakul W. Prevention of Emerging Infections in Children Pediatric clinics of North America 69(1):185-202 2022 [PMID: 34794674]
  2. Hoff NA, Bratcher A, Mukadi P, Ahuka S, Kabamba M, Musene K, Halbrook M, Dzogong C, Mwamba GN, Mbala P, Kelly JD, Kompany JP, Tambu M, Kaba D, Kebela-Ilunga B, Muyemebe-Tamfum JJ, Rimoin AW. Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo Vaccine 2021 [PMID: 34799143]
  3. Jannat K, Paul AK, Bondhon TA, Hasan A, Nawaz M, Jahan R, Mahboob T, Nissapatorn V, Wilairatana P, Pereira ML, Rahmatullah M. Nanotechnology Applications of Flavonoids for Viral Diseases Pharmaceutics 13(11) 2021 [PMID: 34834309]
  4. Pinski AN, Messaoudi I. Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity Current opinion in virology 51:179-189 2021 [PMID: 34749265]
  5. Ma Z, Zhu M, Zhang S, Qian K, Wang C, Fu W, Lei C, Hu S. Therapeutic antibodies under development for SARS-CoV-2 View (Beijing, China) :20200178 2021 [PMID: 34766160]
  6. Bose P, Roy S, Ghosh P. A Comparative NLP-Based Study on the Current Trends and Future Directions in COVID-19 Research IEEE access : practical innovations, open solutions 9:78341-78355 2021 [PMID: 34786315]

Escherichia coli

  1. Lueangyangyuen A, Senapin S, Dong HT, Unajak S, Wangkahart E, Khunrae P. Expression and purification of S5<sub>196-272</sub> and S6<sub>200-317</sub> proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines Protein expression and purification 190:106013 2022 [PMID: 34752859]
  2. Alves MLF, Moreira GMSG, Ferreira MRA, Donassolo RA, Moreira C Jr, Rodrigues RR, Conceição FR. Clostridium spp. Toxins: A Practical Guide for Expression and Characterization in Escherichia coli Methods in molecular biology (Clifton, N.J.) 2411:117-125 2022 [PMID: 34816402]
  3. Moreira C Jr, Moreira GMSG, Donassolo RA, Ferreira MRA, Alves MLF, Rodrigues RR, Conceição FR. Recombinant Escherichia coli Cell Lysates as a Low-Cost Alternative for Vaccines Against Veterinary Clostridial Diseases Methods in molecular biology (Clifton, N.J.) 2411:105-115 2022 [PMID: 34816401]
  4. Kay EJ, Terra VS. Production of Vaccines Using Biological Conjugation Methods in molecular biology (Clifton, N.J.) 2414:281-300 2022 [PMID: 34784042]
  5. Hirayama S, Nakao R. Glycine Induction Method: Effective Production of Immunoactive Bacterial Membrane Vesicles with Low Endotoxin Content Methods in molecular biology (Clifton, N.J.) 2414:207-226 2022 [PMID: 34784040]
  6. Li S, Lee KH, Zhang W. Multiepitope Fusion Antigen: MEFA, an Epitope- and Structure-Based Vaccinology Platform for Multivalent Vaccine Development Methods in molecular biology (Clifton, N.J.) 2414:151-169 2022 [PMID: 34784037]
  7. Lee JS, Yoon S, Han SJ, Kim ED, Kim J, Shin HS, Seo KY. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics Expert review of vaccines :1-11 2021 [PMID: 34788181]
  8. Xu Q, Liu S, Kassegne K, Yang B, Lu J, Sun Y, Zhong W, Zhang M, Liu Y, Zhu G, Cao J, Cheng Y. Genetic diversity and immunogenicity of the merozoite surface protein 1 C-terminal 19-kDa fragment of Plasmodium ovale imported from Africa into China Parasites & vectors 14(1):583 2021 [PMID: 34819151]
  9. Geng T, Luo L, Wang Y, Shen B, Fang R, Hu M, Zhao J, Zhou Y. Evaluation of immunoprotective effects of recombinant proteins and DNA vaccines derived from Eimeria tenella surface antigen 6 and 15 in vivo Parasitology research 2021 [PMID: 34816300]
  10. Alalam H, Sigurdardóttir S, Bourgard C, Tiukova I, King RD, Grøtli M, Sunnerhagen P. A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease mSystems :e0108721 2021 [PMID: 34812651]
  11. Zia MA, Shah MS, Shafqat Ali Khan R, Farooq U, Shafi J, Habib M. High level expression and purification of recombinant 3ABC non-structural protein of foot-and-mouth disease virus using SUMO fusion system Protein expression and purification :106025 2021 [PMID: 34826607]
  12. Luz D, Gómez FD, Ferreira RL, Melo BS, Guth BEC, Quintilio W, Moro AM, Presta A, Sacerdoti F, Ibarra C, Chen G, Sidhu SS, Amaral MM, Piazza RMF. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody Toxins 13(11) 2021 [PMID: 34822608]
  13. Arévalo-Herrera M, Miura K, Solano E, Sebastián Ramírez J, Long CA, Corradin G, Herrera S. Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice Vaccine 2021 [PMID: 34802791]
  14. Dzudzor B, Amenyedor A, Amarh V, Armah GE. Detection of Enterotoxigenic Escherichia coli in Rotavirus-Infected Ghanaian Children Diagnosed with Acute Gastroenteritis The American journal of tropical medicine and hygiene 2021 [PMID: 34781263]
  15. Iwasaki M, Kanehara R, Yamaji T, Katagiri R, Mutoh M, Tsunematsu Y, Sato M, Watanabe K, Hosomi K, Kakugawa Y, Ikematsu H, Hotta K, Kunisawa J, Wakabayashi K, Matsuda T. Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan Cancer science 2021 [PMID: 34779109]
  16. Hyun M, Lee JY, Kim HA. Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients Annals of clinical microbiology and antimicrobials 20(1):77 2021 [PMID: 34758824]
  17. Svennerholm AM, Qadri F, Lundgren A, Kaim J, Rahman Bhuiyan T, Akhtar M, Maier N, Louis Bourgeois A, Walker RI. Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants Vaccine 2021 [PMID: 34772542]
  18. Thapa HB, Müller AM, Camilli A, Schild S. An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2 Frontiers in microbiology 12:752739 2021 [PMID: 34803974]
  19. Xu Q, Zhou W, Ding S, Lu Y, Liu S, Cao J, Zhang Z, Liu S, Yu S. An Escherichia coli carrier vaccine with surface-displayed protein MAP3061c elicits protective immunity against Mycobacterium paratuberculosis in mice Research in veterinary science 141:180-189 2021 [PMID: 34763254]
  20. Ferrer F, Roldão M, Figueiredo C, Lopes K. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion Nephron :1-5 2021 [PMID: 34724668]
  21. Kumar K, Ong HK, Tan WS, Arshad SS, Ho KL. Immunological Analysis of Nodavirus Capsid Displaying the Domain III of Japanese Encephalitis Virus Envelope Protein Pharmaceutics 13(11) 2021 [PMID: 34834244]
  22. Mostaan S, Ghasemzadeh A, Asadi Karam MR, Ehsani P, Sardari S, Shokrgozar MA, Abolhassani M, Nikbakht Brujeni G. <i>Pasteurella multocida</i> PlpE Protein Polytope as a Potential Subunit Vaccine Candidate Vector borne and zoonotic diseases (Larchmont, N.Y.) 21(11):870-874 2021 [PMID: 34788150]
  23. Yang C, Li Y, Zuo L, Jiang M, Zhang X, Xie L, Luo M, She Y, Wang L, Jiang Y, Wu S, Cai R, Shi X, Cui Y, Wan C, Hu Q. Genomic Epidemiology and Antimicrobial Susceptibility Profile of Enterotoxigenic <i>Escherichia coli</i> From Outpatients With Diarrhea in Shenzhen, China, 2015-2020 Frontiers in microbiology 12:732068 2021 [PMID: 34777281]
  24. Mariotti S, Capocefalo A, Chiantore MV, Iacobino A, Teloni R, De Angelis ML, Gallinaro A, Pirillo MF, Borghi M, Canitano A, Michelini Z, Baggieri M, Marchi A, Bucci P, McKay PF, Acchioni C, Sandini S, Sgarbanti M, Tosini F, Di Virgilio A, Venturi G, Marino F, Esposito V, Di Bonito P, Magurano F, Cara A, Negri D, Nisini R. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency Frontiers in immunology 12:750386 2021 [PMID: 34764961]
  25. Kromann S, Olsen RH, Bojesen AM, Jensen HE, Thøfner I. Protective Potential of an Autogenous Vaccine in an Aerogenous Model of <i>Escherichia coli</i> Infection in Broiler Breeders Vaccines 9(11) 2021 [PMID: 34835164]
  26. Zerna G, Rathinasamy VA, Toet H, Anderson G, Dempster R, Spithill TW, Beddoe T. Evaluation of Immunogenicity and Efficacy of <i>Fasciola hepatica</i> Tetraspanin 2 (TSP2) Fused to <i>E. coli</i> Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle Vaccines 9(11) 2021 [PMID: 34835144]

Francisella tularensis (Tularemia)

  1. Markley RL, Restori KH, Katkere B, Sumner SE, Nicol MJ, Tyryshkina A, Nettleford SK, Williamson DR, Place DE, Dewan KK, Shay AE, Carlson BA, Girirajan S, Prabhu KS, Kirimanjeswara GS. Macrophage Selenoproteins Restrict Intracellular Replication of <i>Francisella tularensis</i> and Are Essential for Host Immunity Frontiers in immunology 12:701341 2021 [PMID: 34777335]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Dastjerdi S, Malikan M, Akgöz B, Civalek Ö, Wiczenbach T, Eremeyev VA. On the deformation and frequency analyses of SARS-CoV-2 at nanoscale International journal of engineering science 170:103604 2022 [PMID: 34728858]
  2. Ekstrand ML, Heylen E, Gandhi M, Steward WT, Pereira M, Srinivasan K. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns Journal of acquired immune deficiency syndromes (1999) 88(5):421-425 2021 [PMID: 34757971]
  3. Samaranayake L, Fakhruddin KS. Pandemics past, present, and future: Their impact on oral health care Journal of the American Dental Association (1939) 152(12):972-980 2021 [PMID: 34749921]
  4. Irungu EM, Mugwanya KK, Mugo NR, Bukusi EA, Donnell D, Odoyo J, Wamoni E, Peacock S, Morton JF, Ngure K, Mugambi M, Mukui I, O'Malley G, Baeten JM. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial The Lancet. Global health 9(12):e1730-e1739 2021 [PMID: 34798031]
  5. Gonsalves GS, Salomon JA, Thornhill T, Paltiel AD. Adventures in COVID-19 Policy Modeling: Education Edition Current HIV/AIDS reports 2021 [PMID: 34826066]
  6. Koga M, Senkoji T, Kubota M, Ishizaka A, Mizutani T, Sedohara A, Ikeuchi K, Kikuchi T, Adachi E, Saito M, Koibuchi T, Hosomichi K, Ohashi J, Kawana-Tachikawa A, Matano T, Tsutsumi T, Yotsuyanagi H. Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen<sup>®</sup> , for people living with HIV Hepatology research : the official journal of the Japan Society of Hepatology 2021 [PMID: 34825436]
  7. Randhawa A, Kapila R, Schwartz RA. Leprosy: what is new International journal of dermatology 2021 [PMID: 34826151]
  8. Maltezou HC, Panagopoulos P, Sourri F, Giannouchos TV, Raftopoulos V, Gamaletsou MN, Karapanou A, Koukou DM, Koutsidou A, Peskelidou E, Papanastasiou K, Souliotis K, Lourida A, Sipsas NV, Hatzigeorgiou D. COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study Vaccine 39(48):7021-7027 2021 [PMID: 34740473]
  9. Mousa A, Winskill P, Watson OJ, Ratmann O, Monod M, Ajelli M, Diallo A, Dodd PJ, Grijalva CG, Kiti MC, Krishnan A, Kumar R, Kumar S, Kwok KO, Lanata CF, le Polain de Waroux O, Leung K, Mahikul W, Melegaro A, Morrow CD, Mossong J, Neal EF, Nokes DJ, Pan-Ngum W, Potter GE, Russell FM, Saha S, Sugimoto JD, Wei WI, Wood RR, Wu J, Zhang J, Walker P, Whittaker C. Social contact patterns and implications for infectious disease transmission: a systematic review and meta-analysis of contact surveys eLife 10 2021 [PMID: 34821551]
  10. Hasanshahi Z, Hashempour A, Ghasabi F, Moayedi J, Musavi Z, Dehghani B, Sharafi H, Joulaei H. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients BMC gastroenterology 21(1):443 2021 [PMID: 34819046]
  11. Wang M, Zhang L, Li Q, Wang B, Liang Z, Sun Y, Nie J, Wu J, Su X, Qu X, Li Y, Wang Y, Huang W. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination Emerging microbes & infections :1-30 2021 [PMID: 34818119]
  12. Holguin L, Echavarria L, Burnetta JC. Novel humanized-PBMC mouse model with delayed onset of GVHD for preclinical HIV research Journal of virology :JVI0139421 2021 [PMID: 34818071]
  13. Wu C, He Y, Zhao J, Luo K, Wen Z, Zhang Y, Li M, Cui Y, Liu Z, Wang C, Han Z, Li G, Feng F, Li P, Chen L, Sun C. Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption Journal of virology :JVI0178521 2021 [PMID: 34818070]
  14. Maeda K, Amano M, Uemura Y, Tsuchiya K, Matsushima T, Noda K, Shimizu Y, Fujiwara A, Takamatsu Y, Ichikawa Y, Nishimura H, Kinoshita M, Matsumoto S, Gatanaga H, Yoshimura K, Oka SI, Mikami A, Sugiura W, Sato T, Yoshida T, Shimada S, Mitsuya H. Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals Scientific reports 11(1):22848 2021 [PMID: 34819514]
  15. Escolano A, Gristick HB, Gautam R, DeLaitsch AT, Abernathy ME, Yang Z, Wang H, Hoffmann MAG, Nishimura Y, Wang Z, Koranda N, Kakutani LM, Gao H, Gnanapragasam PNP, Raina H, Gazumyan A, Cipolla M, Oliveira TY, Ramos V, Irvine DJ, Silva M, West AP Jr, Keeffe JR, Barnes CO, Seaman MS, Nussenzweig MC, Martin MA, Bjorkman PJ. Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env Science translational medicine 13(621):eabk1533 2021 [PMID: 34818054]
  16. Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial Science (New York, N.Y.) :eab3435 2021 [PMID: 34812653]
  17. Mohapi L, Pinedo Y, Osiyemi O, Supparatpinyo K, Ratanasuwan W, Molina JM, Dagan R, Tamms G, Sterling T, Zhang Y, Pedley A, Hartzel J, Kan Y, Hurtado K, Musey L, Simon JK, Buchwald UK. Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study AIDS (London, England) 2021 [PMID: 34750291]
  18. Han S, Williamson BD, Fong Y. Improving random forest predictions in small datasets from two-phase sampling designs BMC medical informatics and decision making 21(1):322 2021 [PMID: 34809631]
  19. Wang Y, Qian G, Zhu L, Zhao Z, Liu Y, Han W, Zhang X, Zhang Y, Xiong T, Zeng H, Yu X, Yu X, Zhang X, Xu J, Zou Q, Yan D. HIV-1 Vif suppresses antiviral immunity by targeting STING Cellular & molecular immunology 2021 [PMID: 34811497]
  20. Abdulhaqq S, Ventura AB, Reed JS, Bashirova AA, Bateman KB, McDonald E, Wu HL, Greene JM, Schell JB, Morrow D, Wisskirchen K, Martin JN, Deeks SG, Carrington M, Protzer U, Früh K, Hansen SG, Picker LJ, Sacha JB, Bimber BN. Identification and Characterization of Antigen-Specific CD8<sup>+</sup> T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing Journal of immunology (Baltimore, Md. : 1950) 2021 [PMID: 34810222]
  21. Zong G, Toonstra C, Yang Q, Zhang R, Wang LX. Chemoenzymatic Synthesis and Antibody Binding of HIV-1 V1/V2 Glycopeptide-Bacteriophage Q<i>β</i> Conjugates as a Vaccine Candidate International journal of molecular sciences 22(22) 2021 [PMID: 34830420]
  22. Eto Y, Saubi N, Ferrer P, Joseph-Munné J. Expression of Chimeric HPV-HIV Protein L1P18 in <i>Pichia pastoris</i>; Purification and Characterization of the Virus-like Particles Pharmaceutics 13(11) 2021 [PMID: 34834382]
  23. Rui RM, Tang CR, Zhang CT, Pan WK, Gan K, Luo RH, Wei ZQ, Jing FS, Huang SM, Yang LM, Li YM, Wang YP, Xiao WL, Zhang HB, Zheng YT, He YP. C6-structural optimizations of 2-aryl-1H-pyrazole-S-DABOs: From anti-HIV to anti-DENV activity Bioorganic chemistry :105494 2021 [PMID: 34836643]
  24. Lv Z, Li Q, Feng Z, Zheng X, NaYin, Yang H, Gu Q, Ying S, Qi Y, Li X, Wu R, Wu Z, Yu X, Zou N, Qin D, Wan C. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV International immunopharmacology :108383 2021 [PMID: 34824035]
  25. Fulda ES, Fitch KV, Overton ET, Zanni MV, Aberg JA, Currier JS, Lu MT, Malvestutto C, Fichtenbaum CJ, Martinez E, Umbleja T, Douglas PS, Ribaudo HJ, Grinspoon SK. COVID-19 Vaccination Rates in a Global HIV Cohort The Journal of infectious diseases 2021 [PMID: 34794178]
  26. Friedrich N, Stiegeler E, Glögl M, Lemmin T, Hansen S, Kadelka C, Wu Y, Ernst P, Maliqi L, Foulkes C, Morin M, Eroglu M, Liechti T, Ivan B, Reinberg T, Schaefer JV, Karakus U, Ursprung S, Mann A, Rusert P, Kouyos RD, Robinson JA, Günthard HF, Plückthun A, Trkola A. Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization Nature communications 12(1):6705 2021 [PMID: 34795280]
  27. Blain AE, Reese HE, Marjuki H, Topaz N, Mbaeyi S, McNamara LA. Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018 Vaccine 2021 [PMID: 34802785]
  28. Li S, Wang B, Jiang S, Pan Y, Shi Y, Kong W, Shan Y. Surface-Functionalized Silica-Coated Calcium Phosphate Nanoparticles Efficiently Deliver DNA-Based HIV-1 Trimeric Envelope Vaccines against HIV-1 ACS applied materials & interfaces 13(45):53630-53645 2021 [PMID: 34735127]
  29. Ejaz M, Mubarak M, Ali TS, Andersson S, Ekström AM. Human papillomavirus-associated anal squamous intraepithelial lesions in men who have sex with men and transgender women living with and without HIV in Karachi Pakistan: implications for screening and prevention BMC infectious diseases 21(1):1163 2021 [PMID: 34789177]
  30. Hoehn KB, Turner JS, Miller FI, Jiang R, Pybus OG, Ellebedy AH, Kleinstein SH. Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving eLife 10 2021 [PMID: 34787567]
  31. Hemsath JR, Liaci AM, Rubin JD, Parrett BJ, Lu SC, Nguyen TV, Turner MA, Chen CY, Cupelli K, Reddy VS, Stehle T, Liszewski MK, Atkinson JP, Barry MA. <i>Ex Vivo</i> and <i>In Vivo</i> CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26) Journal of virology :JVI0082621 2021 [PMID: 34787457]
  32. Hayes P, Fernandez N, Ochsenbauer C, Dalel J, Hare J, King D, Black L, Streatfield C, Kakarla V, Macharia G, Makinde J, Price M, Hunter E, Gilmour J. Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set PloS one 16(11):e0260118 2021 [PMID: 34788349]
  33. Vanetti C, Trabattoni D, Stracuzzi M, Amendola A, Fappani C, Rubinacci V, Fenizia C, Gianolio L, Biasin M, Dighera A, Saulle I, Tanzi E, Zuccotti G, Clerici M, Giacomet V. Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals Cells 10(11) 2021 [PMID: 34831410]
  34. Duarte G, Muresan P, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Fenton T, Coutinho CM, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Machado ES, Kreitchman R, Chakhtoura N, Mussi-Pinhata MM, Weinberg A. Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV The Journal of infectious diseases 2021 [PMID: 34791324]
  35. Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Yassine HM, Benslimane FM, Al Khatib HA, Tang P, Hasan MR, Coyle P, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Butt AA, Al Romaihi HE, Al-Thani MH, Al Khal A, Bertollini R. Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar JAMA 326(19):1930-1939 2021 [PMID: 34724027]
  36. Paquin-Proulx D, Lal KG, Phuang-Ngern Y, Creegan M, Tokarev A, Suhkumvittaya S, Alrubayyi A, Kroon E, Pinyakorn S, Slike BM, Bolton DL, Krebs SJ, Eller LA, Sajjaweerawan C, Pagliuzza A, Chomont N, Rerknimitr R, Chomchey N, Phanuphak N, de Souza MS, Michael NL, Robb ML, Ananworanich J, Sandberg JK, Eller MA, Schuetz A. Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosa Proceedings of the National Academy of Sciences of the United States of America 118(46) 2021 [PMID: 34753817]
  37. Duke ER, Boshier FAT, Boeckh M, Schiffer JT, Cardozo-Ojeda EF. Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation Viruses 13(11) 2021 [PMID: 34835098]
  38. Carlander C, Lagheden C, Eklund C, Nordqvist Kleppe S, Dzabic M, Wagner P, Sparén P, Dillner J. Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment AIDS (London, England) 35(14):2367-2374 2021 [PMID: 34723851]
  39. Sigalov AB. SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale Biochimie 2021 [PMID: 34793886]
  40. Jewkes R, Milovanovic M, Otwombe K, Chirwa E, Hlongwane K, Hill N, Mbowane V, Matuludi M, Hopkins K, Gray G, Coetzee J. Intersections of Sex Work, Mental Ill-Health, IPV and Other Violence Experienced by Female Sex Workers: Findings from a Cross-Sectional Community-Centric National Study in South Africa International journal of environmental research and public health 18(22) 2021 [PMID: 34831727]
  41. Bruzzese E, Pagano F, Diana A, Punzi L, Guarino A. Protection of Vaccine Preventable Diseases in a Population of HIV-Infected Children: A 3 Years Prospective Study Vaccines 9(11) 2021 [PMID: 34835262]
  42. Wholey WY, Yoda ST, Cheng W. Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice Bioconjugate chemistry 2021 [PMID: 34775749]
  43. Mann JFS, McKay PF, Klein K, Pankrac J, Tregoning JS, Shattock RJ. Blocking T cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity Immunology 2021 [PMID: 34775601]
  44. Restuccia D, Carrión-Nessi FS, Omaña-Ávila ÓD, Mendoza-Millán DL, Mejía-Bernard MD, Marcano-Rojas MV, Quintero A, Gasparini S, Chacón FR, Basso JG, Rodríguez VA, Forero-Peña DA. Prevalence of undiagnosed HIV in Venezuelan patients with suspected COVID-19 during the first wave: A complex syndemic Travel medicine and infectious disease 44:102207 2021 [PMID: 34785375]
  45. Halperin DT, Hearst N, Hodgins S, Bailey RC, Klausner JD, Jackson H, Wamai RG, Ladapo JA, Over M, Baral S, Escandón K, Gandhi M. Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here BMC public health 21(1):2084 2021 [PMID: 34774012]
  46. Dorosti H, Eskandari S, Zarei M, Nezafat N, Ghasemi Y. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 96:105136 2021 [PMID: 34775078]
  47. Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, Moreira ED Jr, Baraldi E, Jessen H, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Bautista O, Das R, Group T, Luxembourg A, Zhou HJ, Saah A. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial The Lancet. Infectious diseases 2021 [PMID: 34780705]
  48. Peluso MJ, Donatelli J, Henrich TJ. LONG-TERM IMMUNOLOGIC EFFECTS OF SARS-CoV-2 INFECTION: LEVERAGING TRANSLATIONAL RESEARCH METHODOLOGY TO ADDRESS EMERGING QUESTIONS Translational research : the journal of laboratory and clinical medicine 2021 [PMID: 34780969]
  49. Mitchell JL, Pollara J, Dietze K, Edwards RW, Nohara J, N'guessan KF, Zemil M, Buranapraditkun S, Takata H, Li Y, Muir R, Kroon E, Pinyakorn S, Jha S, Manasnayakorn S, Chottanapund S, Thantiworasit P, Prueksakaew P, Ratnaratorn N, Nuntapinit B, Fox L, Tovanabutra S, Paquin-Proulx D, Wieczorek L, Polonis VR, Maldarelli F, Haddad EK, Phanuphak P, Sacdalan CP, Rolland M, Phanuphak N, Ananworanich J, Vasan S, Ferrari G, Trautmann L. Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection The Journal of clinical investigation 2021 [PMID: 34762600]
  50. Stuckler D, McKee M, Kentikelenis A. Are we making the same mistakes in fighting COVID‑19 as in past pandemics? Lessons from HIV show the urgent need to invest in HPSR Public health research & practice 31(4) 2021 [PMID: 34753161]
  51. Bunyasi EW, Middelkoop K, Koch A, Hoosen Z, Mulenga H, Luabeya AKK, Shenje J, Mendelsohn SC, Tameris M, Scriba TJ, Warner DF, Wood R, Andrews JR, Hatherill M. <b>Molecular Detection of Airborne <i>Mycobacterium tuberculosis</i> in South African High Schools</b> American journal of respiratory and critical care medicine 2021 [PMID: 34752730]
  52. Jorgensen SC, Miljanic S, Tabbara N, Somanader D, Tse CL, Castro C, Malhamé I, Lapinsky SE, Burry L. Characterizing the inclusion of pregnant and breastfeeding people in infectious diseases randomized controlled trials: a targeted literature review Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2021 [PMID: 34768020]
  53. Egloff C, Mergui JL, Uzan C, Canlorbe G. [Management of HPV-induced cervical lesions in immunosuppressed patients - Review of the literature] Gynecologie, obstetrique, fertilite & senologie 2021 [PMID: 34768006]
  54. Reynolds Z, McCluskey SM, Moosa MYS, Gilbert RF, Pillay S, Aturinda I, Ard KL, Muyindike W, Musinguzi N, Masette G, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson BA, Gandhi RT, Sunpath H, Marconi VC, Bwana MB, Siedner MJ. Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa HIV medicine 2021 [PMID: 34755438]
  55. Ivleva VB, Gowetski DB, Lei QP. Streamlining Peptide Mapping LC-MS Approach for Studying Fusion Peptide-Conjugated Vaccine Immunogens Journal of the American Society for Mass Spectrometry 2021 [PMID: 34751576]
  56. Stockdale AJ, Meiring JE, Shawa IT, Thindwa D, Silungwe NM, Mbewe M, Kachala R, Kreuels B, Patel P, Patel P, Henrion MYR, Bar-Zeev N, Swarthout TD, Heyderman RS, Gordon SB, Geretti AM, Gordon MA. Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi The Journal of infectious diseases 2021 [PMID: 34752631]
  57. Chan KW, Luo CC, Lu H, Wu X, Kong XP. A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1 Nature communications 12(1):6464 2021 [PMID: 34753944]
  58. Lee M, Changela A, Gorman J, Rawi R, Bylund T, Chao CW, Lin BC, Louder MK, Olia AS, Zhang B, Doria-Rose NA, Zolla-Pazner S, Shapiro L, Chuang GY, Kwong PD. Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces Nature communications 12(1):6470 2021 [PMID: 34753907]
  59. Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, Wang Y, Lewis MG, Pierson TC, Barbosa C, Tam Y, Matyas GR, Rao M, Beck Z, Shen X, Ferrari G, Tomaras GD, Montefiori DC, Weissman D, Haynes BF. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates NPJ vaccines 6(1):136 2021 [PMID: 34743171]
  60. Miner MD, Bekker LG, Kredo T, Bhagwandin N, Corey L, Gray GE. Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017 Trials 22(1):778 2021 [PMID: 34742340]
  61. Qi L, Yang L, Ge J, Yu L, Li X. COVID-19 Vaccination Behavior of People Living with HIV: The Mediating Role of Perceived Risk and Vaccination Intention Vaccines 9(11) 2021 [PMID: 34835219]
  62. Gouhar SA, Elshahid ZA. Molecular docking and simulation studies of synthetic protease inhibitors against COVID-19: a computational study Journal of biomolecular structure & dynamics :1-21 2021 [PMID: 34738871]
  63. Hausken K, Ncube M. A Game Theoretic Analysis of Competition Between Vaccine and Drug Companies during Disease Contraction and Recovery Medical decision making : an international journal of the Society for Medical Decision Making :272989X211053563 2021 [PMID: 34738510]
  64. Martin CA, Marshall C, Patel P, Goss C, Jenkins DR, Ellwood C, Barton L, Price A, Brunskill NJ, Khunti K, Pareek M. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study PLoS medicine 18(11):e1003823 2021 [PMID: 34739480]
  65. Chapman R, van Diepen M, Douglass N, Galant S, Jaffer M, Margolin E, Ximba P, Hermanus T, Moore PL, Williamson AL. Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV Vaccines 9(11) 2021 [PMID: 34835214]
  66. Fredericksen RJ, Whitney BM, Trejo E, Nance RM, Fitzsimmons E, Altice FL, Carrico AW, Cleland CM, Del Rio C, Duerr A, El-Sadr WM, Kahana S, Kuo I, Mayer K, Mehta S, Ouellet LJ, Quan VM, Rich J, Seal DW, Springer S, Taxman F, Wechsberg W, Crane HM, Delaney JAC. Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort BMC public health 21(1):2002 2021 [PMID: 34736425]
  67. Brenchley JM, Ortiz AM. Microbiome Studies in Non-human Primates Current HIV/AIDS reports 2021 [PMID: 34735686]
  68. Fu W, Sivajohan B, McClymont E, Albert A, Elwood C, Ogilvie G, Money D. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2021 [PMID: 34735722]
  69. Songtaweesin WN, LeGrand S, Bandara S, Piccone C, Wongharn P, Moonwong J, Jupimai T, Saisaengjan C, Theerawit T, Muessig K, Hightow-Weidman L, Puthanakit T, Phanuphak N, Tangmunkongvorakul A. Adaptation of a Theory-Based Social Networking and Gamified App-Based Intervention to Improve Pre-Exposure Prophylaxis Adherence Among Young Men Who Have Sex With Men in Bangkok, Thailand: Qualitative Study Journal of medical Internet research 23(11):e23852 2021 [PMID: 34734828]
  70. Nosik M, Ryzhov K, Rymanova I, Sobkin A, Kravtchenko A, Kuimova U, Pokrovsky V, Zverev V, Svitich O. Dynamics of Plasmatic Levels of Pro- and Anti-Inflammatory Cytokines in HIV-Infected Individuals with <i>M. tuberculosis</i> Co-Infection Microorganisms 9(11) 2021 [PMID: 34835417]
  71. Miller RH, Zimmer A, Moutot G, Mesnard JM, Chazal N. Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution? Viruses 13(11) 2021 [PMID: 34835027]
  72. Muñoz-Moreno JA, Carrillo-Molina S, Martínez-Zalacaín I, Miranda C, Manzardo C, Coll P, Meulbroek M, Hanke T, Garolera M, Miró JM, Brander C, Clotet B, Soriano-Mas C, Moltó J, Mothe B. Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy AIDS (London, England) 2021 [PMID: 34750296]
  73. Mu Z, Haynes BF, Cain DW. Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination Current opinion in virology 51:172-178 2021 [PMID: 34742037]
  74. Siracusano G, Brombin C, Pastori C, Cugnata F, Noviello M, Tassi E, Princi D, Cantoni D, Malnati MS, Maugeri N, Bozzi C, Saretto G, Clementi N, Mancini N, Uberti-Foppa C, Temperton N, Bonini C, Di Serio C, Lopalco L. Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection Frontiers in immunology 12:772239 2021 [PMID: 34804064]
  75. Mielke D, Stanfield-Oakley S, Borate B, Fisher LH, Faircloth K, Tuyishime M, Greene K, Gao H, Williamson C, Morris L, Ochsenbauer C, Tomaras G, Haynes BF, Montefiori D, Pollara J, deCamp AC, Ferrari G. Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies Journal of virology :JVI0164321 2021 [PMID: 34730393]
  76. Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study Lancet (London, England) 2021 [PMID: 34741816]
  77. Hokello J, Sharma AL, Tyagi P, Bhushan A, Tyagi M. Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System Vaccines 9(11) 2021 [PMID: 34835203]
  78. Gebre MS, Rauch S, Roth N, Gergen J, Yu J, Liu X, Cole AC, Mueller SO, Petsch B, Barouch DH. mRNA Vaccines Induce Rapid Antibody Responses in Mice bioRxiv : the preprint server for biology 2021 [PMID: 34751269]
  79. Cottrell CA, Manne K, Kong R, Wang S, Zhou T, Chuang GY, Edwards RJ, Henderson R, Janowska K, Kopp M, Lin BC, Louder MK, Olia AS, Rawi R, Shen CH, Taft JD, Torres JL, Wu NR, Zhang B, Doria-Rose NA, Cohen MS, Haynes BF, Shapiro L, Ward AB, Acharya P, Mascola JR, Kwong PD. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies Cell reports 37(5):109922 2021 [PMID: 34731616]
  80. Siracusano G, Finardi A, Pastori C, Martinelli V, Furlan R, Lopalco L. HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model Frontiers in immunology 12:771359 2021 [PMID: 34795677]
  81. Silva-Nash J, Bordelon S, Searcy SA, Dare RK. Standardizing HIV post-exposure prophylaxis in the emergency department following sexual assault HIV medicine 2021 [PMID: 34725910]
  82. Jedicke N, Stankov MV, Cossmann A, Dopfer-Jablonka A, Knuth C, Ahrenstorf G, Ramos GM, Behrens GMN. Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy HIV medicine 2021 [PMID: 34725907]
  83. McCall B, Shallcross L, Wilson M, Fuller C, Hayward A. Storytelling as a Research Tool Used to Explore Insights and as an Intervention in Public Health: A Systematic Narrative Review International journal of public health 66:1604262 2021 [PMID: 34795554]
  84. Ou T, He W, Quinlan BD, Guo Y, Tran MH, Karunadharma P, Park H, Davis-Gardner ME, Yin Y, Zhang X, Wang H, Zhong G, Farzan M. Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire Molecular therapy : the journal of the American Society of Gene Therapy 2021 [PMID: 34740791]
  85. Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, AlMukdad S, Coyle P, Ayoub HH, Al Kanaani Z, Al Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Nasrallah GK, Al Kuwari MG, Al Romaihi HE, Butt AA, Al-Thani MH, Al Khal A, Bertollini R, Abu-Raddad LJ. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar Nature medicine 2021 [PMID: 34728831]
  86. Sliepen K, Schermer E, Bontjer I, Burger JA, Lévai RF, Mundsperger P, Brouwer PJM, Tolazzi M, Farsang A, Katinger D, Moore JP, Scarlatti G, Shattock RJ, Sattentau QJ, Sanders RW. Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers NPJ vaccines 6(1):134 2021 [PMID: 34728634]
  87. Salih RQ, Salih GA, Abdulla BA, Ahmed AD, Mohammed HR, Kakamad FH, Salih AM. False-positive HIV in a patient with SARS-CoV-2 infection; a case report Annals of medicine and surgery (2012) 71:103027 2021 [PMID: 34777794]
  88. Ejaz M, Andersson S, Batool S, Ali T, Ekström AM. Anal human papillomavirus infection among men who have sex with men and transgender women living with and without HIV in Pakistan: findings from a cross-sectional study BMJ open 11(11):e052176 2021 [PMID: 34725079]
  89. Wang Y. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines EBioMedicine 73:103677 2021 [PMID: 34742128]
  90. Wurcel AG, Chen G, Zubiago JA, Reyes J, Nowotny KM. Heterogeneity in Jail Nursing Medical Intake Forms: A Content Analysis Journal of correctional health care : the official journal of the National Commission on Correctional Health Care 2021 [PMID: 34724807]
  91. Williams WB, Wiehe K, Saunders KO, Haynes BF. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies Journal of the International AIDS Society 24 Suppl 7:e25831 2021 [PMID: 34806332]
  92. Luba M, Yola N, Newells R, Mwakyosi LB. HIV prevention today: do we still need a vaccine? A community perspective Journal of the International AIDS Society 24 Suppl 7:e25806 2021 [PMID: 34806322]
  93. Johnston MI, Scarlatti G, Pitisutthithum P, Bekker LG. HIV vaccines: progress and promise Journal of the International AIDS Society 24 Suppl 7:e25828 2021 [PMID: 34806319]
  94. Tatoud R, Snow W, Esparza J. A transformed global enterprise for an HIV vaccine Journal of the International AIDS Society 24 Suppl 7:e25822 2021 [PMID: 34806318]
  95. Miner MD, Corey L, Montefiori D. Broadly neutralizing monoclonal antibodies for HIV prevention Journal of the International AIDS Society 24 Suppl 7:e25829 2021 [PMID: 34806308]
  96. Fauci AS, Dieffenbach CW, Dabis F. Fitting a vaccine into the HIV prevention landscape Journal of the International AIDS Society 24 Suppl 7:e25792 2021 [PMID: 34806307]
  97. Feinberg MB, Russell ND, Shattock RJ, Youngdahl KB. The importance of partnerships in accelerating HIV vaccine research and development Journal of the International AIDS Society 24 Suppl 7:e25824 2021 [PMID: 34806306]
  98. Derking R, Sanders RW. Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review Journal of the International AIDS Society 24 Suppl 7:e25797 2021 [PMID: 34806305]
  99. Slack C, Ndebele P, Allen M, Salzwedel J. Shifts in UNAIDS ethics guidance and implications for ethics review of preventive HIV vaccine trials Journal of the International AIDS Society 24 Suppl 7:e25796 2021 [PMID: 34806302]
  100. Kim J, Vasan S, Kim JH, Ake JA. Current approaches to HIV vaccine development: a narrative review Journal of the International AIDS Society 24 Suppl 7:e25793 2021 [PMID: 34806296]
  101. Wang H, Jonas KJ. The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach Journal of the International AIDS Society 24(11):e25841 2021 [PMID: 34797952]
  102. Hiv TL. Prioritise people with HIV for COVID-19 vaccination The lancet. HIV 8(11):e659 2021 [PMID: 34735800]
  103. Jantarabenjakul W, Chantasrisawad N, Puthanakit T, Wacharapluesadee S, Hirankarn N, Ruenjaiman V, Paitoonpong L, Suwanpimolkul G, Torvorapanit P, Pradit R, Sophonphan J, Putcharoen O. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers Asian Pacific journal of allergy and immunology 2021 [PMID: 34717527]
  104. Soriano V, Alvarez C, Edagwa B, de Mendoza C, Montoya N, Treviño A, Gendelman H. Ultra-long-acting (XLA) antivirals for chronic viral hepatitis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 114:45-50 2021 [PMID: 34728344]
  105. Cheng HD, Dowell KG, Bailey-Kellogg C, Goods BA, Love JC, Ferrari G, Alter G, Gach J, Forthal DN, Lewis GK, Greene K, Gao H, Montefiori DC, Ackerman ME. Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features Retrovirology 18(1):35 2021 [PMID: 34717659]
  106. Dorlass EG, Lourenço KL, Magalhães RDM, Sato H, Fiorini A, Peixoto R, Coelho HP, Telezynski BL, Scagion GP, Ometto T, Thomazelli LM, Oliveira DBL, Fernandes AP, Durigon EL, Fonseca FG, Teixeira SMR. Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy Genomics 113(6):4109-4115 2021 [PMID: 34718131]
  107. Holms RD, Ataullakhanov RI. Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity International journal of molecular sciences 22(21) 2021 [PMID: 34769119]
  108. Gargan S, Stevenson NJ. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease Viruses 13(11) 2021 [PMID: 34834972]
  109. Currenti J, Law BMP, Qin K, John M, Pilkinton MA, Bansal A, Leary S, Ram R, Chopra A, Gangula R, Yue L, Warren C, Barnett L, Alves E, McDonnell WJ, Sooda A, Heath SL, Mallal S, Goepfert P, Kalams SA, Gaudieri S. Cross-Reactivity to Mutated Viral Immune Targets Can Influence CD8<sup>+</sup> T Cell Functionality: An Alternative Viral Adaptation Strategy Frontiers in immunology 12:746986 2021 [PMID: 34764960]
  110. Mbuya W, Held K, Mcharo RD, Haule A, Mhizde J, Mnkai J, Mahenge A, Mwakatima M, Sembo M, Mwalongo W, Agrea P, Hoelscher M, Maboko L, Saathoff E, Geisenberger O, Rwegoshora F, Torres L, Koup RA, Kroidl A, Chachage M, Geldmacher C. Depletion of Human Papilloma Virus E6- and E7-Oncoprotein-Specific T-Cell Responses in Women Living With HIV Frontiers in immunology 12:742861 2021 [PMID: 34759925]
  111. Awad SF, Musuka G, Mukandavire Z, Froass D, MacKinnon NJ, Cuadros DF. Implementation of a Vaccination Program Based on Epidemic Geospatial Attributes: COVID-19 Pandemic in Ohio as a Case Study and Proof of Concept Vaccines 9(11) 2021 [PMID: 34835173]
  112. Liu D, Zhang S, Poteet E, Marin-Muller C, Chen C, Yao Q. Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV Vaccines 9(11) 2021 [PMID: 34835167]
  113. Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure Frontiers in immunology 12:757400 2021 [PMID: 34745130]
  114. Zhang Y, Zheng S, Zhao W, Mao Y, Cao W, Zeng W, Liu Y, Hu L, Gong M, Cheng J, Chen Y, Yang H. Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS Frontiers in immunology 12:755568 2021 [PMID: 34745128]
  115. Tiecco G, Degli Antoni M, Storti S, Marchese V, Focà E, Torti C, Castelli F, Quiros-Roldan E. A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines Pathogens (Basel, Switzerland) 10(11) 2021 [PMID: 34832520]
  116. Sarkar S, Spencer DA, Barnette P, Pandey S, Sutton WF, Basu M, Burch RE, Cleveland JD, Rosenberg AF, Rangel-Moreno J, Keefer MC, Hessell AJ, Haigwood NL, Kobie JJ. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques Frontiers in immunology 12:757811 2021 [PMID: 34745131]
  117. Yaffe ZA, Overbaugh J. HIV-1 protection: Antibodies move in for the kill Cell reports. Medicine 2(10):100428 2021 [PMID: 34755139]
  118. Griffith SA, McCoy LE. To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1 Frontiers in immunology 12:708227 2021 [PMID: 34737737]
  119. Tamgue O, Mezajou CF, Ngongang NN, Kameni C, Ngum JA, Simo USF, Tatang FJ, Akami M, Ngono AN. Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases Frontiers in immunology 12:703936 2021 [PMID: 34737736]
  120. Bjerkan L, Visweswaran GRR, Gudjonsson A, Labbé GM, Quinkert D, Pattinson DJ, Spång HCL, Draper SJ, Bogen B, Braathen R. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces <i>Plasmodium falciparum</i>-Specific Neutralizing Antibodies and T Cell Responses Frontiers in immunology 12:720550 2021 [PMID: 34733274]
  121. Rees CA, Hooli S, King C, McCollum ED, Colbourn T, Lufesi N, Mwansambo C, Lazzerini M, Madhi SA, Cutland C, Nunes M, Gessner BD, Basnet S, Kartasasmita CB, Mathew JL, Zaman SMAU, Paranhos-Baccala G, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Santosham M, Picot VS, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Chou M, Rakoto-Andrianarivelo M, Wang J, Nymadawa P, Vanhems P, Russomando G, Asghar R, Banajeh S, Iqbal I, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Singhi S, Thea DM, Clara AW, Campbell H, Nair H, Falconer J, Williams LJ, Horne M, Strand T, Qazi SA, Nisar YB, Neuman MI. External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia Journal of global health 11:04062 2021 [PMID: 34737862]
  122. Bieńkowski C, Siwak E, Kowalska JD. Measles Seroprevalence and Vaccine Responses in HIV-Positive Patients Open forum infectious diseases 8(11):ofab505 2021 [PMID: 34805435]
  123. Bona R, Michelini Z, Mazzei C, Gallinaro A, Canitano A, Borghi M, Vescio MF, Di Virgilio A, Pirillo MF, Klotman ME, Negri D, Cara A. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization Molecular therapy. Methods & clinical development 23:263-275 2021 [PMID: 34729374]
  124. Jordan A, Mills K, Sobukonla T, Kelly A, Flood M. Influenza, PCV13, and PPSV23 Vaccination Rates Among Inflammatory Bowel Disease Patients With Additional Co-Morbidities as per CDC Recommendations Cureus 13(9):e18387 2021 [PMID: 34729268]
  125. Feng YL, Chang Y, Shi J, Lan GH, Lu HY, Xiang SM, Wang FZ, Wang SP. [Immunization effect and persistence of hepatitis B vaccine in HIV-infected patients with different CD4<sup>+</sup>T cell levels] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 42(9):1559-1565 2021 [PMID: 34814584]
  126. Jain V, Doernberg SB, Holubar M, Huang B, Bollyky J, Sample H, Weng Y, Lu D, Desai M, Maldonado Y, Rutherford G. High Completion of COVID-19 Vaccination Among Health Care Workers Despite Initial Self-Reported Vaccine Reluctance Open forum infectious diseases 8(10):ofab446 2021 [PMID: 34734101]
  127. Onay A, Ertaş A, Süzerer V, Yener İ, Yilmaz MA, Ayaz-Tilkat E, Ekinci R, Bozhan N, Irtegün-Kandemir S. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy? Turkish journal of biology = Turk biyoloji dergisi 45(4):570-587 2021 [PMID: 34803455]
  128. Tania M, Asad A, Li T, Islam MS, Islam SB, Hossen MM, Bhuiyan MR, Khan MA. Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics Iranian journal of basic medical sciences 24(8):1014-1022 2021 [PMID: 34804418]
  129. Ma Z, Zhu M, Zhang S, Qian K, Wang C, Fu W, Lei C, Hu S. Therapeutic antibodies under development for SARS-CoV-2 View (Beijing, China) :20200178 2021 [PMID: 34766160]
  130. Isara A, Baldeh AK. Prevalence of sexually transmitted infections among pregnant women attending antenatal clinics in West Coast Region of The Gambia African health sciences 21(2):585-592 2021 [PMID: 34795711]
  131. Groaz E, De Clercq E, Herdewijn P. Anno 2021: Which antivirals for the coming decade? Annual reports in medicinal chemistry 57:49-4107 2021 [PMID: 34744210]
  132. Mehta KS, Marfatia YS, Jain AP, Shah DJ, Baxi DS. Male circumcision and Sexually transmitted Infections - An update Indian journal of sexually transmitted diseases and AIDS 42(1):1-6 2021 [PMID: 34765930]

Lassa virus

  1. Voss G, Jacquet JM, Tornieporth N, Kampmann B, Karron R, Meulen AS, Chen R, Gruber M, Lurie N, Weller C, Cramer JP, Saville M, Darko M. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020 Vaccine 2021 [PMID: 34799142]
  2. Murphy HL, Ly H. Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments Virulence 2021 [PMID: 34747339]

Marburg virus

  1. Marzi A, Jankeel A, Menicucci AR, Callison J, O'Donnell KL, Feldmann F, Pinski AN, Hanley PW, Messaoudi I. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease Frontiers in immunology 12:774026 2021 [PMID: 34777392]

Mycobacterium tuberculosis (tuberculosis)

  1. Ashhurst AS, Hanna CC, Payne RJ, Britton WJ. Immunological Assessment of Lung Responses to Inhalational Lipoprotein Vaccines Against Bacterial Pathogens Methods in molecular biology (Clifton, N.J.) 2414:301-323 2022 [PMID: 34784043]
  2. Martinez L, Nicol MP, Wedderburn CJ, Stadler A, Botha M, Workman L, le Roux DM, Zar HJ. Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa The Lancet. Global health 9(12):e1740-e1749 2021 [PMID: 34798032]
  3. Logesh R, Lavanya V, Jamal S, Ahmed N. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach Applied biochemistry and biotechnology 2021 [PMID: 34817805]
  4. Jansson MK, Neuber K, Rudolf H, Podbielski A, Virchow JC, Warnke P. Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection Allergy 2021 [PMID: 34812526]
  5. Flynn D, Ogi A, Subedi S, Langton J, Choong K, O'Donnell J. Mycotic aortic aneurysm formation following intravesical BCG treatment for transitional cell carcinoma of the bladder BMJ case reports 14(11) 2021 [PMID: 34815228]
  6. Bäckdahl T, Sharma M. Knowledge and transmission risk awareness of tuberculosis among the pilgrims attending a religious mass gathering in India: a cross-sectional study BMC public health 21(1):2141 2021 [PMID: 34809593]
  7. Jenum S, Tonby K, Rueegg CS, Rühwald M, Kristiansen MP, Bang P, Olsen IC, Sellæg K, Røstad K, Mustafa T, Taskén K, Kvale D, Mortensen R, Dyrhol-Riise AM. A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients Nature communications 12(1):6774 2021 [PMID: 34811370]
  8. Irvine EB, O'Neil A, Darrah PA, Shin S, Choudhary A, Li W, Honnen W, Mehra S, Kaushal D, Gideon HP, Flynn JL, Roederer M, Seder RA, Pinter A, Fortune S, Alter G. Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques Nature immunology 2021 [PMID: 34811542]
  9. Woodworth JS, Clemmensen HS, Battey H, Dijkman K, Lindenstrøm T, Laureano RS, Taplitz R, Morgan J, Aagaard C, Rosenkrands I, Lindestam Arlehamn CS, Andersen P, Mortensen R. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin Nature communications 12(1):6658 2021 [PMID: 34795205]
  10. Muflihah H, Flórido M, Lin LCW, Xia Y, Triccas JA, Stambas J, Britton WJ. Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection PloS one 16(11):e0259829 2021 [PMID: 34793507]
  11. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, Prieto-Merino D, Cousens S, Black RE, Liu L. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals The Lancet. Child & adolescent health 2021 [PMID: 34800370]
  12. Brugère-Picoux J, Leroy E, Angot JL, Rosolen SG. [Human and animal health] Bulletin de l'Academie nationale de medecine 2021 [PMID: 34803168]
  13. Kong L, Moorlag SJCFM, Lefkovith A, Li B, Matzaraki V, van Emst L, Kang HA, Latorre I, Jaeger M, Joosten LAB, Netea MG, Xavier RJ. Single-cell transcriptomic profiles reveal changes associated with BCG-induced trained immunity and protective effects in circulating monocytes Cell reports 37(7):110028 2021 [PMID: 34788625]
  14. Jewkes R, Milovanovic M, Otwombe K, Chirwa E, Hlongwane K, Hill N, Mbowane V, Matuludi M, Hopkins K, Gray G, Coetzee J. Intersections of Sex Work, Mental Ill-Health, IPV and Other Violence Experienced by Female Sex Workers: Findings from a Cross-Sectional Community-Centric National Study in South Africa International journal of environmental research and public health 18(22) 2021 [PMID: 34831727]
  15. Tangie E, Walters A, Hsu NJ, Fisher M, Magez S, Jacobs M, Keeton R. BCG mediated protection against M. tuberculosis is sustained post malaria infection independent of parasite virulence Immunology 2021 [PMID: 34775598]
  16. Zheng J, Liu L, Wei C, Liu B, Jin Q. Characterization of O-mannosylated proteins profiling in bacillus Calmette-Guérin via gel-based and gel-free approaches IUBMB life 2021 [PMID: 34773437]
  17. Unsworth-White SR, Kitchen MO, Bryan RT. Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies Future oncology (London, England) :0 2021 [PMID: 34763531]
  18. da Silva ASM, Albuquerque LHP, de Ponte CGG, de Almeida MR, de Faria SER, Ribeiro MDS, Pereira ENGDS, Antas PRZ. Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile <i>in vitro</i> when compared with Russia, Pasteur, and Danish strains Human vaccines & immunotherapeutics :1-7 2021 [PMID: 34766868]
  19. . Tuberculosis and COVID-19 co-infection: description of the global cohort The European respiratory journal 2021 [PMID: 34764184]
  20. Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J. TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO) Human vaccines & immunotherapeutics :1-29 2021 [PMID: 34762551]
  21. Kumar NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, Nancy A, Jayadeepa B, Selvaraj N, Asokan D, Renji RM, Venkataramani V, Tripathy S, Babu S. BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common γc cytokines in elderly individuals PloS one 16(11):e0258743 2021 [PMID: 34758029]
  22. Bunyasi EW, Middelkoop K, Koch A, Hoosen Z, Mulenga H, Luabeya AKK, Shenje J, Mendelsohn SC, Tameris M, Scriba TJ, Warner DF, Wood R, Andrews JR, Hatherill M. <b>Molecular Detection of Airborne <i>Mycobacterium tuberculosis</i> in South African High Schools</b> American journal of respiratory and critical care medicine 2021 [PMID: 34752730]
  23. Finotti P. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19? Cell stress & chaperones 2021 [PMID: 34755305]
  24. Albutti A. An integrated computational framework to design a multi-epitopes vaccine against Mycobacterium tuberculosis Scientific reports 11(1):21929 2021 [PMID: 34753983]
  25. Borgio JF, Rasdan AS, Sonbol B, Alhamid G, Almandil NB, AbdulAzeez S. Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula Biology 10(11) 2021 [PMID: 34827138]
  26. Harvey M, Chislett B, Perera M, Lawrentschuk N, Bolton D, Jack G. Critical shortage in BCG immunotherapy: How did we get here and where will it take us? Urologic oncology 2021 [PMID: 34750053]
  27. Moon D, Kim S, Kim MH, Jeong D, Choi H. Contracting Out National Immunization Program Does Not Improve Vaccination Rate Nor Socioeconomic Inequality: A Case Study of Seasonal Influenza Vaccination in South Korea Frontiers in public health 9:769176 2021 [PMID: 34805079]
  28. Nosik M, Ryzhov K, Rymanova I, Sobkin A, Kravtchenko A, Kuimova U, Pokrovsky V, Zverev V, Svitich O. Dynamics of Plasmatic Levels of Pro- and Anti-Inflammatory Cytokines in HIV-Infected Individuals with <i>M. tuberculosis</i> Co-Infection Microorganisms 9(11) 2021 [PMID: 34835417]
  29. Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Vaccines 9(11) 2021 [PMID: 34835204]
  30. Behura A, Das M, Kumar A, Naik L, Mishra A, Manna D, Patel S, Mishra A, Singh R, Dhiman R. ESAT-6 impedes IL-18 mediated phagosome lysosome fusion via microRNA-30a upon Calcimycin treatment in mycobacteria infected macrophages International immunopharmacology 101(Pt A):108319 2021 [PMID: 34740079]
  31. Singh M, Tiwari P, Arora G, Agarwal S, Kidwai S, Singh R. Author Correction: Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis Scientific reports 11(1):21824 2021 [PMID: 34728648]
  32. Jafari H, Saarlas KN, Schluter WW, Espinal M, Ijaz K, Gregory C, Filler S, Wolff C, Krause LK, O'Brien K, Pearson L, Gupta A, Rebollo Polo M, Shuaib F. Rethinking public health campaigns in the COVID-19 era: a call to improve effectiveness, equity and impact BMJ global health 6(11) 2021 [PMID: 34836913]
  33. Il'in DA, Shkurupy VA, Akhramenko ES. In Vitro Study of the Expression of CD1, CD14, CD25, CD30, CD35, CD95 Receptors by Macrophages of Mice Infected with Mycobacterium tuberculosis Bulletin of experimental biology and medicine 172(1):42-45 2021 [PMID: 34796425]
  34. Ferrer F, Roldão M, Figueiredo C, Lopes K. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion Nephron :1-5 2021 [PMID: 34724668]
  35. Komine-Aizawa S, Mizuno S, Matsuo K, Namiki T, Hayakawa S, Honda M. Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against <i>Mycobacterium kansasii</i> Vaccines 9(11) 2021 [PMID: 34835191]
  36. Soriano V, Alvarez C, Edagwa B, de Mendoza C, Montoya N, Treviño A, Gendelman H. Ultra-long-acting (XLA) antivirals for chronic viral hepatitis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 114:45-50 2021 [PMID: 34728344]
  37. Medha, Priyanka, Sharma S, Sharma M. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 168:106051 2021 [PMID: 34744006]
  38. Ahmad F, Umar MS, Khan N, Jamal F, Gupta P, Zubair S, Gupta UD, Owais M. Immunotherapy With 5, 15-DPP Mediates Macrophage M1 Polarization and Modulates Subsequent <i>Mycobacterium tuberculosis</i> Infectivity in rBCG30 Immunized Mice Frontiers in immunology 12:706727 2021 [PMID: 34777338]
  39. Ahmed SM, Nasr MA, Elshenawy SE, Hussein AE, El-Betar AH, Mohamed RH, El-Badri N. BCG vaccination and the risk of COVID 19: A possible correlation Virology 565:73-81 2021 [PMID: 34742127]
  40. Enriquez AB, Izzo A, Miller SM, Stewart EL, Mahon RN, Frank DJ, Evans JT, Rengarajan J, Triccas JA. Advancing Adjuvants for <i>Mycobacterium tuberculosis</i> Therapeutics Frontiers in immunology 12:740117 2021 [PMID: 34759923]
  41. Khambati N, Olbrich L, Ellner J, Salgame P, Song R, Bijker EM. Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review Frontiers in pediatrics 9:756043 2021 [PMID: 34760853]
  42. Zhang Y, Zhao R, Zhang Z, Liu Q, Zhang A, Ren Q, Li S, Long X, Xu H. Analysis of Factors Influencing Multidrug-Resistant Tuberculosis and Validation of Whole-Genome Sequencing in Children with Drug-Resistant Tuberculosis Infection and drug resistance 14:4375-4393 2021 [PMID: 34729015]
  43. Assal N, Rennie B, Walrond L, Cyr T, Rohonczy L, Lin M. Proteome characterization of the culture supernatant of <i>Mycobacterium bovis</i> in different growth stages Biochemistry and biophysics reports 28:101154 2021 [PMID: 34746449]
  44. Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy Frontiers in microbiology 12:745592 2021 [PMID: 34745048]
  45. Shaikh N, Pelzer PT, Thysen SM, Roy P, Harris RC, White RG. Impact of COVID-19 Disruptions on Global BCG Coverage and Paediatric TB Mortality: A Modelling Study Vaccines 9(11) 2021 [PMID: 34835161]
  46. Mouhoub E, Domenech P, Ndao M, Reed MB. The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview Frontiers in microbiology 12:757858 2021 [PMID: 34745066]
  47. Tamgue O, Mezajou CF, Ngongang NN, Kameni C, Ngum JA, Simo USF, Tatang FJ, Akami M, Ngono AN. Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases Frontiers in immunology 12:703936 2021 [PMID: 34737736]
  48. Kumar NP, Banurekha VV, C P GK, Nancy A, Padmapriyadarsini C, Mary AS, Devi KRU, Murhekar M, Babu S. Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses Frontiers in immunology 12:752397 2021 [PMID: 34721425]
  49. Keating T, Lethbridge S, Allnutt JC, Hendon-Dunn CL, Thomas SR, Alderwick LJ, Taylor SC, Bacon J. <i>Mycobacterium tuberculosis</i> modifies cell wall carbohydrates during biofilm growth with a concomitant reduction in complement activation Cell surface (Amsterdam, Netherlands) 7:100065 2021 [PMID: 34778603]
  50. Soyak Aytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, Kiper N, Tezcan I, Cagdas D. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single-centre study Scandinavian journal of immunology 94(4):e13084 2021 [PMID: 34780073]
  51. Nemati Shizari L, Mohammadpour Dounighi N, Bayat M, Mosavari N. A New Amphotericin B-loaded Trimethyl Chitosan Nanoparticles as a Drug Delivery System and Antifungal Activity on <i>Candida albicans</i> Biofilm Archives of Razi Institute 76(3):571-586 2021 [PMID: 34824750]
  52. Tania M, Asad A, Li T, Islam MS, Islam SB, Hossen MM, Bhuiyan MR, Khan MA. Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics Iranian journal of basic medical sciences 24(8):1014-1022 2021 [PMID: 34804418]
  53. Muniyandi M, Singh M, Singh M, Rajshekhar K, Katoch K. Cost-effectiveness of incorporating <i>Mycobacterium indicus pranii</i> vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes &amp; immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India The Indian journal of medical research 154(1):121-131 2021 [PMID: 34782538]
  54. Lee S, Lee W, Kang SK. Tuberculosis infection status and risk factors among health workers: an updated systematic review Annals of occupational and environmental medicine 33:e17 2021 [PMID: 34754478]
  55. Nadal R, Apolo AB, Girardi DM, Hahn NM, Bellmunt J. Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer Urologic oncology 2020 [PMID: 34756410]

Nipah virus

  1. Jannat K, Paul AK, Bondhon TA, Hasan A, Nawaz M, Jahan R, Mahboob T, Nissapatorn V, Wilairatana P, Pereira ML, Rahmatullah M. Nanotechnology Applications of Flavonoids for Viral Diseases Pharmaceutics 13(11) 2021 [PMID: 34834309]
  2. Shrestha N, Gall FM, Mathieu C, Hierweger MM, Brügger M, Alves MP, Vesin J, Banfi D, Kalbermatter D, Horvat B, Chambon M, Turcatti G, Fotiadis D, Riedl R, Plattet P. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier mBio :e0262121 2021 [PMID: 34724816]
  3. Gómez Román R, Tornieporth N, Cherian NG, Shurtleff AC, L'Azou Jackson M, Yeskey D, Hacker A, Mungai E, Le TT. Medical countermeasures against henipaviruses: a review and public health perspective The Lancet. Infectious diseases 2021 [PMID: 34735799]

Plasmodium falciparum (Malaria)

  1. Forgie EME, Brooks HM, Barton M, Hawkes MT. Pediatric Malaria: Global and North American Perspectives Pediatric clinics of North America 69(1):47-64 2022 [PMID: 34794676]
  2. Vijayan V. Vaccines for International Pediatric Travelers Pediatric clinics of North America 69(1):171-184 2022 [PMID: 34794673]
  3. Elmi T, Hajialiani F, Asadi MR, Sadeghi S, Namazi MJ, Tabatabaie F, Zamani Z. Antimalarial effects of the hydroalcoholic extract of <i>Allium paradoxum</i> in vitro and in vivo Journal of parasitic diseases : official organ of the Indian Society for Parasitology 45(4):1055-1064 2021 [PMID: 34789989]
  4. Xu Q, Liu S, Kassegne K, Yang B, Lu J, Sun Y, Zhong W, Zhang M, Liu Y, Zhu G, Cao J, Cheng Y. Genetic diversity and immunogenicity of the merozoite surface protein 1 C-terminal 19-kDa fragment of Plasmodium ovale imported from Africa into China Parasites & vectors 14(1):583 2021 [PMID: 34819151]
  5. Heath WR, Holz LE, Fernandez-Ruiz D. The Batman and Robin of liver-stage immunity to malaria Trends in parasitology 2021 [PMID: 34836817]
  6. Webster R, Sekuloski S, Odedra A, Woolley S, Jennings H, Amante F, Trenholme KR, Healer J, Cowman AF, Eriksson EM, Sathe P, Penington J, Blanch AJ, Dixon MWA, Tilley L, Duffy MF, Craig A, Storm J, Chan JA, Evans K, Papenfuss AT, Schofield L, Griffin P, Barber BE, Andrew D, Boyle MJ, de Labastida Rivera F, Engwerda C, McCarthy JS. Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine BMC medicine 19(1):293 2021 [PMID: 34802442]
  7. da Cruz DL, Paiva MHS, Guedes DRD, de Souza Gomes EC, Pires SG, Gomez LF, Ayres CFJ. First report of the L1014F kdr mutation in wild populations of Anopheles arabiensis in Cabo Verde, West Africa Parasites & vectors 14(1):582 2021 [PMID: 34802463]
  8. Renn JP, Doritchamou JYA, Tentokam BCN, Morrison RD, Cowles MV, Burkhardt M, Ma R, Tolia NH, Fried M, Duffy PE. Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity Communications biology 4(1):1309 2021 [PMID: 34799664]
  9. Cha SJ, Kim MS, Na CH, Jacobs-Lorena M. Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes Nature communications 12(1):6773 2021 [PMID: 34799567]
  10. Sissoko MS, Healy SA, Katile A, Zaidi I, Hu Z, Kamate B, Samake Y, Sissoko K, Mwakingwe-Omari A, Lane J, Imeru A, Mohan R, Thera I, Guindo CO, Dolo A, Niare K, Koïta F, Niangaly A, Rausch KM, Zeguime A, Guindo MA, Bah A, Abebe Y, James ER, Manoj A, Murshedkar T, Kc N, Sim BKL, Billingsley PF, Richie TL, Hoffman SL, Doumbo O, Duffy PE. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial The Lancet. Infectious diseases 2021 [PMID: 34801112]
  11. Daubenberger C. Assessment of experimental malaria vaccine induced protection in pre-exposed populations The Lancet. Infectious diseases 2021 [PMID: 34801111]
  12. Galactionova K, Smith TA, Penny MA. Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S Malaria journal 20(1):439 2021 [PMID: 34794430]
  13. Guiu G, Monin J, Perrier E, Manen O. Travel health study in commercial aircrew members Travel medicine and infectious disease 45:102209 2021 [PMID: 34800693]
  14. Arévalo-Herrera M, Miura K, Solano E, Sebastián Ramírez J, Long CA, Corradin G, Herrera S. Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice Vaccine 2021 [PMID: 34802791]
  15. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, Prieto-Merino D, Cousens S, Black RE, Liu L. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals The Lancet. Child & adolescent health 2021 [PMID: 34800370]
  16. Unwin HJT, Mwandigha L, Winskill P, Ghani AC, Hogan AB. Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage Malaria journal 20(1):438 2021 [PMID: 34789253]
  17. Inbar E, Eappen AG, Alford RT, Reid W, Harrell RA, Hosseini M, Chakravarty S, Li T, Sim BKL, Billingsley PF, Hoffman SL. Knockout of Anopheles stephensi immune gene LRIM1 by CRISPR-Cas9 reveals its unexpected role in reproduction and vector competence PLoS pathogens 17(11):e1009770 2021 [PMID: 34784388]
  18. Jewkes R, Milovanovic M, Otwombe K, Chirwa E, Hlongwane K, Hill N, Mbowane V, Matuludi M, Hopkins K, Gray G, Coetzee J. Intersections of Sex Work, Mental Ill-Health, IPV and Other Violence Experienced by Female Sex Workers: Findings from a Cross-Sectional Community-Centric National Study in South Africa International journal of environmental research and public health 18(22) 2021 [PMID: 34831727]
  19. Tangie E, Walters A, Hsu NJ, Fisher M, Magez S, Jacobs M, Keeton R. BCG mediated protection against M. tuberculosis is sustained post malaria infection independent of parasite virulence Immunology 2021 [PMID: 34775598]
  20. Woon SA, Manning L, Moore BR. Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research priorities Parasitology international 87:102512 2021 [PMID: 34785369]
  21. Kordes M, Ormond L, Rausch S, Matuschewski K, Hafalla JCR. TLR9 signalling inhibits Plasmodium liver infection by macrophage activation European journal of immunology 2021 [PMID: 34773640]
  22. Doolan DL. Malaria research in Australia: looking through the lens of the past towards the future International journal for parasitology 2021 [PMID: 34780720]
  23. Kratochvil S, Shen CH, Lin YC, Xu K, Nair U, Da Silva Pereira L, Tripathi P, Arnold J, Chuang GY, Melzi E, Schön A, Zhang B, Dillon M, Bonilla B, Flynn BJ, Kirsch KH, Kisalu NK, Kiyuka PK, Liu T, Ou L, Pancera M, Rawi R, Reveiz M, Seignon K, Wang LT, Waring MT, Warner J, Yang Y, Francica JR, Idris AH, Seder RA, Kwong PD, Batista FD. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies Immunity 2021 [PMID: 34788599]
  24. Mohamed NS, AbdElbagi H, Elsadig AR, Ahmed AE, Mohammed YO, Elssir LT, Elnour MB, Ali Y, Ali MS, Altahir O, Abubakr M, Siddig EE, Ahmed A, Omer RA. Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate Malaria journal 20(1):436 2021 [PMID: 34758827]
  25. Debnath N, Thakur M, Khushboo, Negi NP, Gautam V, Kumar Yadav A, Kumar D. Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges Biotechnology and bioengineering 2021 [PMID: 34755343]
  26. Grundy B, Panzner U, Liu J, Jeon HJ, Im J, von Kalckreuth V, Konings F, Pak GD, Cruz Espinoza LM, Bassiahi AS, Gasmelseed N, Rakotozandrindrainy RL, Stroup S, Houpt E, Marks F. Detection of Pathogens of Acute Febrile Illness Using Polymerase Chain Reaction from Dried Blood Spots The American journal of tropical medicine and hygiene 2021 [PMID: 34749309]
  27. Sookpongthai P, Utayopas K, Sitthiyotha T, Pengsakul T, Kaewthamasorn M, Wangkanont K, Harnyuttanakorn P, Chunsrivirot S, Pattaradilokrat S. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate Parasites & vectors 14(1):571 2021 [PMID: 34749796]
  28. Flores-Garcia Y, Wang LT, Park M, Asady B, Idris AH, Kisalu NK, Muñoz C, Pereira LS, Francica JR, Seder RA, Zavala F. The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo PLoS pathogens 17(11):e1010042 2021 [PMID: 34748617]
  29. Walter NS, Gorki V, Chauhan M, Dhingra N, Kaur S. Sinigrin in combination with artesunate provides protection against lethal murine malaria via falcipain-3 inhibition and immune modulation International immunopharmacology 101(Pt A):108320 2021 [PMID: 34741871]
  30. Jha P, Gahlawat A, Bhattacharyya S, Dey S, Kumar KA, Bhattacharyya MK. Bloom Helicase Along with Recombinase Rad51 Repairs the Mitochondrial Genome of the Malaria Parasite mSphere :e0071821 2021 [PMID: 34730376]
  31. Fantin RF, Fraga VG, Lopes CA, de Azevedo IC, Reis-Cunha JL, Pereira DB, Lobo FP, de Oliveira MM, Dos Santos AC, Bartholomeu DC, Fujiwara RT, Bueno LL. New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates PloS one 16(11):e0258637 2021 [PMID: 34727117]
  32. Siddiqui AJ, Bhardwaj J, Hamadou WS, Goyal M, Ashraf SA, Jahan S, Jamal A, Sharma P, Sachidanandan M, Badraoui R, Adnan M. Chemoprophylaxis under sporozoites-lumefantrine (CPS-LMF) immunization induce protective immune responses against <i>Plasmodium yoelii</i> sporozoites infection in mice 3 Biotech 11(11):465 2021 [PMID: 34745816]
  33. Parapini S, Paone S, Erba E, Cavicchini L, Pourshaban M, Celani F, Contini A, D'Alessandro S, Olivieri A. In vitro antimalarial activity of inhibitors of the human GTPase Rac1 Antimicrobial agents and chemotherapy :AAC0149821 2021 [PMID: 34723630]
  34. Jafari H, Saarlas KN, Schluter WW, Espinal M, Ijaz K, Gregory C, Filler S, Wolff C, Krause LK, O'Brien K, Pearson L, Gupta A, Rebollo Polo M, Shuaib F. Rethinking public health campaigns in the COVID-19 era: a call to improve effectiveness, equity and impact BMJ global health 6(11) 2021 [PMID: 34836913]
  35. Gesesew H, Berhane K, Siraj ES, Siraj D, Gebregziabher M, Gebre YG, Gebreslassie SA, Amdes F, Tesema AG, Siraj A, Aregawi M, Gezahegn S, Tesfay FH. The impact of war on the health system of the Tigray region in Ethiopia: an assessment BMJ global health 6(11) 2021 [PMID: 34815244]
  36. Chuang YM, Tang XD, Fikrig E. A mosquito AgTRIO monoclonal antibody reduces early<i>Plasmodium</i> infection of mice Infection and immunity :IAI0035921 2021 [PMID: 34724388]
  37. Nair MS, Huang Y, Fidock DA, Towler MJ, Weathers PJ. Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta Journal of ethnopharmacology 284:114797 2021 [PMID: 34737005]
  38. Soriano V, Alvarez C, Edagwa B, de Mendoza C, Montoya N, Treviño A, Gendelman H. Ultra-long-acting (XLA) antivirals for chronic viral hepatitis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 114:45-50 2021 [PMID: 34728344]
  39. Salvador-Mira M, Chico V, Arostica M, Guzmán F, Roher N, Perez L, Ortega-Villaizan MDM. Immunomodulatory Lectin-like Peptides for Fish Erythrocytes-Targeting as Potential Antiviral Drug Delivery Platforms International journal of molecular sciences 22(21) 2021 [PMID: 34769254]
  40. de Morais CM, de Carvalho Monteiro KH, Brito-Sousa JD, Monteiro WM, Sampaio VS, Endo PT, Kelner J. Malaria Trigram: improving the visualization of recurrence data for malaria elimination Malaria journal 20(1):431 2021 [PMID: 34717641]
  41. Keitany GJ, Jenkins BJ, Obiakor HT, Daniel S, Muehlenbachs A, Semblat JP, Gamain B, Doritchamou JYA, Desai SA, MacDonald NJ, Narum DL, Morrison R, Saveria T, Vignali M, Oleinikov AV, Fried M, Duffy PE. An invariant protein that co-localizes with VAR2CSA on Plasmodium falciparum-infected red cells binds to chondroitin sulfate A The Journal of infectious diseases 2021 [PMID: 34718641]
  42. Fernández L, Solana JC, Sánchez C, Jiménez MÁ, Requena JM, Coler R, Reed SG, Valenzuela JG, Kamhawi S, Oliveira F, Fichera E, Glueck R, Bottazzi ME, Gupta G, Cecilio P, Pérez-Cabezas B, Cordeiro-da-Silva A, Gradoni L, Carrillo E, Moreno J. Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant Microorganisms 9(11) 2021 [PMID: 34835379]
  43. Guan W, Yang S, Zhao Y, Cheng W, Song X, Yao Y, Xie Y, Du W, Li J. Observation of the Gut Microbiota Profile in C57BL/6 Mice Induced by <i>Plasmodium berghei</i> ANKA Infection Frontiers in cellular and infection microbiology 11:680383 2021 [PMID: 34778098]
  44. Chen Q, Wu N, Gao Y, Wang X, Wu J, Ma G. Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy Vaccines 9(11) 2021 [PMID: 34835175]
  45. Khatonier R, Ahmed G, Sarmah P, Narain K, Khan AM. Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis Immunobiology 226(6):152148 2021 [PMID: 34773853]
  46. Bitencourt Chaves L, Guimarães GO, Perce-da-Silva DS, Banic DM, Totino PRR, Machado RLD, Rodrigues-da-Silva RN, Pratt-Riccio LR, Daniel-Ribeiro CT, Lima-Junior JDC. Genetic Diversity of <i>Plasmodium vivax</i> Cysteine-Rich Protective Antigen (PvCyRPA) in Field Isolates from Five Different Areas of the Brazilian Amazon Genes 12(11) 2021 [PMID: 34828264]
  47. Tamgue O, Mezajou CF, Ngongang NN, Kameni C, Ngum JA, Simo USF, Tatang FJ, Akami M, Ngono AN. Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases Frontiers in immunology 12:703936 2021 [PMID: 34737736]
  48. Bjerkan L, Visweswaran GRR, Gudjonsson A, Labbé GM, Quinkert D, Pattinson DJ, Spång HCL, Draper SJ, Bogen B, Braathen R. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces <i>Plasmodium falciparum</i>-Specific Neutralizing Antibodies and T Cell Responses Frontiers in immunology 12:720550 2021 [PMID: 34733274]
  49. Ndungo E, Andronescu LR, Buchwald AG, Lemme-Dumit JM, Mawindo P, Kapoor N, Fairman J, Laufer MK, Pasetti MF. Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis Frontiers in immunology 12:725129 2021 [PMID: 34721387]
  50. Tania M, Asad A, Li T, Islam MS, Islam SB, Hossen MM, Bhuiyan MR, Khan MA. Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics Iranian journal of basic medical sciences 24(8):1014-1022 2021 [PMID: 34804418]

Rickettsia prowazekii (Typhus fever)

  1. Keller C, Rakotozandrindrainy R, von Kalckreuth V, Heriniaina JN, Schwarz NG, Pak GD, Im J, Espinoza LMC, Hagen RM, Frickmann H, Rakotondrainiarivelo JP, Razafindrabe T, Dekker D, May J, Poppert S, Marks F. Molecular Evidence for Flea-Borne Rickettsiosis in Febrile Patients from Madagascar Pathogens (Basel, Switzerland) 10(11) 2021 [PMID: 34832637]

Salmonella

  1. Qamar FN, Hussain W, Qureshi S. Salmonellosis Including Enteric Fever Pediatric clinics of North America 69(1):65-77 2022 [PMID: 34794677]
  2. Meiring JE, Shakya M, Khanam F, Voysey M, Phillips MT, Tonks S, Thindwa D, Darton TC, Dongol S, Karkey A, Zaman K, Baker S, Dolecek C, Dunstan SJ, Dougan G, Holt KE, Heyderman RS, Qadri F, Pitzer VE, Basnyat B, Gordon MA, Clemens J, Pollard AJ. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study The Lancet. Global health 9(12):e1688-e1696 2021 [PMID: 34798028]
  3. Lee JS, Yoon S, Han SJ, Kim ED, Kim J, Shin HS, Seo KY. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics Expert review of vaccines :1-11 2021 [PMID: 34788181]
  4. Zhong X, Du G, Wang X, Ou Y, Wang H, Zhu Y, Hao X, Xie Z, Zhang Y, Gong T, Zhang Z, Sun X. Nanovaccines Mediated Subcutis-to-Intestine Cascade for Improved Protection against Intestinal Infections Small (Weinheim an der Bergstrasse, Germany) :e2105530 2021 [PMID: 34825482]
  5. Andreeva A, Nikolaeva O, Altynbekov O, Arslanova Y. Comparative effectiveness of immune system stimulators in calves' vaccination Journal of experimental zoology. Part A, Ecological and integrative physiology 2021 [PMID: 34813184]
  6. Acevedo-Villanueva KY, Renu S, Shanmugasundaram R, Akerele GO, Gourapura RJ, Selvaraj RK. Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds PloS one 16(11):e0259334 2021 [PMID: 34784366]
  7. Siggins MK, MacLennan CA. An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella Vaccine 2021 [PMID: 34794820]
  8. Selimaj Kontoni V, Lepage P, Hainaut M, Deyi VYM, Maatheus W, Pace D. Paediatric enteric fever in Brussels: a case series over 16 years European journal of pediatrics 2021 [PMID: 34766200]
  9. Park WJ, Yoon YK, Park JS, Pansuriya R, Seok YJ, Ganapathy R. Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine Scientific reports 11(1):22037 2021 [PMID: 34764353]
  10. Aw R, Ashik MR, Islam AAZM, Khan I, Mainuddin M, Islam MA, Ahasan MM, Polizzi KM. Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine Vaccine 2021 [PMID: 34774362]
  11. Hassan AS, Zelt NH, Perera DJ, Xing L, Ndao M, Ward BJ. Correction: Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model PLoS neglected tropical diseases 15(11):e0009936 2021 [PMID: 34735445]
  12. Gerner W, Mair KH, Schmidt S. Local and Systemic T Cell Immunity in Fighting Pig Viral and Bacterial Infections Annual review of animal biosciences 2021 [PMID: 34724393]
  13. Kanteh A, Sesay AK, Alikhan NF, Ikumapayi UN, Salaudeen R, Manneh J, Olatunji Y, Page AJ, Mackenzie G. Invasive atypical non-typhoidal <i>Salmonella</i> serovars in The Gambia Microbial genomics 7(11) 2021 [PMID: 34812716]
  14. Pangilinan CR, Lee CH. Highlights of Immunomodulation in <i>Salmonella</i>-Based Cancer Therapy Biomedicines 9(11) 2021 [PMID: 34829795]
  15. Haile AF, Woodfint RM, Kim E, Joldrichsen MR, Berhe N, Gebreyes WA, Boyaka PN. Broad-Spectrum and Gram-Negative-Targeting Antibiotics Differentially Regulate Antibody Isotype Responses to Injected Vaccines Vaccines 9(11) 2021 [PMID: 34835171]

Shigella

  1. Leow CY, Chuah C, Abdul Majeed AB, Mohd Nor N, Leow CH. Application of Reverse Vaccinology and Immunoinformatic Strategies for the Identification of Vaccine Candidates Against Shigella flexneri Methods in molecular biology (Clifton, N.J.) 2414:17-35 2022 [PMID: 34784029]
  2. Venkatesan MM, Ballou C, Barnoy S, McNeal M, El-Khorazaty J, Frenck R, Baqar S. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding PloS one 16(11):e0259361 2021 [PMID: 34793505]
  3. Arato V, Oldrini D, Massai L, Gasperini G, Necchi F, Micoli F. Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice Microorganisms 9(11) 2021 [PMID: 34835485]
  4. Raso MM, Vassallo O, Micoli F, Giannelli C. Comparison and Optimization of Quantification Methods for <i>Shigella flexneri</i> Serotype 6 O-antigen Containing Galacturonic Acid and Methyl-Pentose International journal of molecular sciences 22(22) 2021 [PMID: 34830042]
  5. Baruah N, Ahamad N, Maiti S, Howlader DR, Bhaumik U, Patil VV, Chakrabarti MK, Koley H, Katti DS. Development of a Self-Adjuvanting, Cross-Protective, Stable Intranasal Recombinant Vaccine for Shigellosis ACS infectious diseases 2021 [PMID: 34734708]
  6. Ullah H, Mahmud S, Hossain MJ, Islam MSB, Kibria KMK. Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular docking confirmation Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 96:105129 2021 [PMID: 34737105]
  7. Chapartegui-González I, Bowser S, Torres AG, Khakhum N. Recent Progress in <i>Shigella</i> and <i>Burkholderia pseudomallei</i> Vaccines Pathogens (Basel, Switzerland) 10(11) 2021 [PMID: 34832508]
  8. Ndungo E, Andronescu LR, Buchwald AG, Lemme-Dumit JM, Mawindo P, Kapoor N, Fairman J, Laufer MK, Pasetti MF. Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis Frontiers in immunology 12:725129 2021 [PMID: 34721387]

Variola major (Smallpox)

  1. Brugère-Picoux J, Leroy E, Angot JL, Rosolen SG. [Human and animal health] Bulletin de l'Academie nationale de medecine 2021 [PMID: 34803168]
  2. Esparza J, Damaso CR. Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis Vaccine 2021 [PMID: 34794823]
  3. Eto A, Yamamoto N, Kanatani Y. Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain Biology 10(11) 2021 [PMID: 34827150]
  4. . Routine Smallpox Vaccination JAMA 326(18):1876 2021 [PMID: 34751721]
  5. Carten JD, Greseth M, Traktman P. Structure-function analysis of two interacting vaccinia proteins that are critical for viral morphogenesis: L2 and A30.5 Journal of virology :JVI0157721 2021 [PMID: 34730390]
  6. Conti AA. Vaccination through time: from the first smallpox vaccine to current vaccination campaigns against the COVID-19 pandemic Acta bio-medica : Atenei Parmensis 92(S6):e2021453 2021 [PMID: 34739474]
  7. Zhang YM, Niu YH. [Understanding of Smallpox in Ancient China] Zhonghua yi shi za zhi (Beijing, China : 1980) 51(5):294-301 2021 [PMID: 34794269]
  8. Yan D, Ra OH, Yan B. The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance Animal diseases 1(1):15 2021 [PMID: 34778881]
  9. Groaz E, De Clercq E, Herdewijn P. Anno 2021: Which antivirals for the coming decade? Annual reports in medicinal chemistry 57:49-4107 2021 [PMID: 34744210]

Venezuelan equine encephalitis virus

  1. Pedraza-Escalona M, Guzmán-Bringas O, Arrieta-Oliva HI, Gómez-Castellano K, Salinas-Trujano J, Torres-Flores J, Muñoz-Herrera JC, Camacho-Sandoval R, Contreras-Pineda P, Chacón-Salinas R, Pérez-Tapia SM, Almagro JC. Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™ BMC infectious diseases 21(1):1121 2021 [PMID: 34717584]

Vibrio cholerae

  1. Erdem R, Ambler G, Al-Ibrahim M, Fraczek K, Dong SD, Gast C, Mercer LD, Raine M, Tennant SM, Chen WH, de Hostos EL, Choy RKM. A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model PLoS neglected tropical diseases 15(11):e0009969 2021 [PMID: 34793441]
  2. McCarty J, Bedell L, de Lame PA, Cassie D, Lock M, Bennett S, Haney D. Update on CVD 103-HgR single-dose, live oral cholera vaccine Expert review of vaccines 2021 [PMID: 34775892]
  3. Thapa HB, Müller AM, Camilli A, Schild S. An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2 Frontiers in microbiology 12:752739 2021 [PMID: 34803974]
  4. Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate Stem cell research & therapy 12(1):564 2021 [PMID: 34732259]
  5. Shan X, Fu J, Li X, Peng X, Chen L. Comparative proteomics and secretomics revealed virulence, and coresistance-related factors in non O1/O139 Vibrio cholerae recovered from 16 species of consumable aquatic animals Journal of proteomics 251:104408 2021 [PMID: 34737110]
  6. Karpov DS, Goncharenko AV, Usachev EV, Vasina DV, Divisenko EV, Chalenko YM, Pochtovyi AA, Ovchinnikov RS, Makarov VV, Yudin SM, Tkachuk AP, Gushchin VA. A Strategy for the Rapid Development of a Safe <i>Vibrio cholerae</i> Candidate Vaccine Strain International journal of molecular sciences 22(21) 2021 [PMID: 34769085]
  7. Bekaert M, Goffin N, McMillan S, Desbois AP. Essential Genes of <i>Vibrio anguillarum</i> and Other <i>Vibrio</i> spp. Guide the Development of New Drugs and Vaccines Frontiers in microbiology 12:755801 2021 [PMID: 34745063]

Yersinia pestis (Plague)

  1. Brugère-Picoux J, Leroy E, Angot JL, Rosolen SG. [Human and animal health] Bulletin de l'Academie nationale de medecine 2021 [PMID: 34803168]
  2. Haq AU, Khan A, Khan J, Irum S, Waheed Y, Ahmad S, Nizam-Uddin N, Albutti A, Zaman N, Hussain Z, Ali SS, Waseem M, Kanwal F, Wei DQ, Wang Q. Annotation of Potential Vaccine Targets and Design of a Multi-Epitope Subunit Vaccine against <i>Yersinia pestis</i> through Reverse Vaccinology and Validation through an Agent-Based Modeling Approach Vaccines 9(11) 2021 [PMID: 34835260]
  3. Matchett MR, Stanley TR, Mccollister MF, Eads DA, Boulerice JT, Biggins DE. Oral Sylvatic Plague Vaccine Does Not Adequately Protect Prairie Dogs (<i>Cynomys</i> spp.) for Endangered Black-Footed Ferret (<i>Mustela nigripes</i>) Conservation Vector borne and zoonotic diseases (Larchmont, N.Y.) 2021 [PMID: 34757815]
  4. Ma L, Li H, Lan J, Hao X, Liu H, Wang X, Huang Y. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic Computational biology and chemistry 95:107599 2021 [PMID: 34773807]
  5. Tiecco G, Degli Antoni M, Storti S, Marchese V, Focà E, Torti C, Castelli F, Quiros-Roldan E. A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines Pathogens (Basel, Switzerland) 10(11) 2021 [PMID: 34832520]

Click HERE to see the publications in the last month.